Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients. However, no effective treatment has yet ...

Please provide your email address to receive an email when new articles are posted on . Memory, attention and psychomotor speed were the most frequently affected cognitive domains linked to MRI ...

Researchers assessed whether early autonomic burden is associated with incident cognitive impairment in patients with prodromal Parkinson disease.

Table 1. Summary of medical therapy (chemotherapy and aromatase inhibitors) and measurements of cognitive functioning (neuropsychological testing and functional imaging) and potential confounders ...

Study identifies plasma free-carnitine deficiency in women with aMCI and early-AD, highlighting mitochondrial metabolism as a target for individualized preventive treatments. Study: Sex differences in ...

In 2023, 9.8% of Louisiana seniors over the age of 65 reported having difficulty remembering, concentrating or making ...

Canine Cognitive Dysfunction (CCD) is a neurodegenerative syndrome affecting aged dogs and is considered the animal counterpart to human dementia, particularly Alzheimer’s disease. CCD manifests as ...

What if the key to better intimacy, sharper memory, and longer life begins in your brain? Discover the science linking love, desire, and the five pillars of brain health.